CLEARSIDE BIOMEDICAL

Clearside BioMedical, an ophthalmic company, specializes in the research, development, and commercialization of therapeutic products through an ocular microinjection platform that targets the individual compartments of the eye. It provides a non-surgical application for dosing drugs to distinct eye tissues, such as the retina, trabecular meshwork, and corneal stroma. The company’s CLS1001 is under development for retinal applications through the delivery of therapeutics to the suprachoroidal space. Clearside BioMedical was incorporated in 2011 and is based in Atlanta, Georgia.

CLEARSIDE BIOMEDICAL

Social Links:

Twitter

Industry:

Biotechnology Health Care Medical Device Pharmaceutical Therapeutics

Founded:

2011-01-01

Address:

Alpharetta, Georgia, United States

Country:

United States

Website Url:

http://www.clearsidebio.com

Total Employee:

11+

Status:

Active

Contact:

(678)270-3631

Email Addresses:

[email protected]

Total Funding:

188.9 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Wordpress Plugins Global Site Tag

Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

axcella-logo

Axcella

Axcella is a biotechnology company providing therapeutics development solutions.

cellular-biomedicine-group-logo

Cellular Biomedicine Group

CBMG is a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancers and stem cell therapies.

crinetics-pharmaceuticals-logo

Crinetics Pharmaceuticals

Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

Current Advisors List

william-d-humphries_image

William D. Humphries Board of Directors @ Clearside Biomedical
Board_member

christy-l-shaffer_image

Christy L. Shaffer Board of Directors @ Clearside Biomedical
Board_member

clay-b-thorp_image

Clay B. Thorp Board of Directors @ Clearside Biomedical
Board_member

christy-l-shaffer_image

Christy L. Shaffer Board Member @ Clearside Biomedical
Board_member
2012-01-01

gerald-cagle_image

Gerald Cagle Member of the Board of Directors @ Clearside Biomedical
Board_member

mark-prausnitz_image

Mark Prausnitz Board Member @ Clearside Biomedical
Board_member
2011-01-01

Current Employees Featured

henry-f-edelhauser_image

Henry F. Edelhauser
Henry F. Edelhauser Vice President, Scientific Affairs @ Clearside Biomedical
Vice President, Scientific Affairs

charlie-deignan_image

Charlie Deignan
Charlie Deignan CFO @ Clearside Biomedical
CFO
2012-01-01

thomas-ciulla_image

Thomas Ciulla
Thomas Ciulla Chief Medical Officer and Chief Development Officer @ Clearside Biomedical
Chief Medical Officer and Chief Development Officer
2020-03-01

henry-f-edelhauser_image

Henry F. Edelhauser
Henry F. Edelhauser Founder @ Clearside Biomedical
Founder

leslie-zacks_image

Leslie Zacks
Leslie Zacks General Counsel & Chief Compliance Officer @ Clearside Biomedical
General Counsel & Chief Compliance Officer
2018-09-01

susan-l-coultas_image

Susan L. Coultas
Susan L. Coultas Chief Clinical Officer @ Clearside Biomedical
Chief Clinical Officer
2022-06-01

george-lasezkay_image

George Lasezkay
George Lasezkay President and Chief Executive Officer @ Clearside Biomedical
President and Chief Executive Officer
2020-03-01

mark-prausnitz_image

Mark Prausnitz
Mark Prausnitz Scientific Founders @ Clearside Biomedical
Scientific Founders
2011-01-01

Founder

henry-f-edelhauser_image

Henry F. Edelhauser

mark-prausnitz_image

Mark Prausnitz

samirkumar-patel_image

Samirkumar Patel

Stock Details

Company's stock symbol is NASDAQ:CLSD

Investors List

healthcare-royalty-partners_image

Key Employee Changes

Date	New article
2022-06-14	Clearside Biomedical Expands Leadership Team with Appointment of Susan Coultas, Ph.D., as Chief Clinical Officer

Official Site Inspections

http://www.clearsidebio.com Semrush global rank: 1.15 M Semrush visits lastest month: 27.52 K

Host Informations
Whois Informations

Loading ...